It will be interesting in future to test these during long term tumor progression in the current Myc-induced HCC model in zebrafish and investigate the combination therapy of anti-VEGF treatment with the inhibition of myeloid cells. This evidence concerns the gene MYC and hepatocellular carcinoma.